Round-up of SAFC's Glasgow conference
03-Oct-2011 By Natalie morrison
SAFC will extend its focus on high potency production through a number of new investments.
AstraZeneca takes its bioinformatics capabilities to Russia
29-Sep-2011
AstraZeneca is will build a center for bioinformatics and predictive medicine in St.Petersburg, Russia by the end of 2011.
News from Sucampo, Tranzyme, and Next Pharma – People on the move
29-Sep-2011 By Natalie Morrison
Outsourcing-Pharma presents its round-up of the latest appointments within the pharmaceutical industry, with news from Sucampo, Tranzyme, and Next Pharma.
Lonza inks stem cell production pact with Mesoblast
28-Sep-2011 By Nick Taylor
Lonza may build a stem cell production facility dedicated to manufacturing Mesoblast products after inking an alliance.
Unigene cuts SDBG to focus gaze on peptides
27-Sep-2011 By Natalie Morrison
Peptide-based therapeutics specialists Unigene will focus on high valuation drug development and drug delivery opportunities after cutting loose its Site Directed Bone Growth (SDBG) patent portfolio.
News from Aduro, Catalent, and Eleven – People on the move
26-Sep-2011 By Natalie Morrison
in-PharmaTechnologist presents its round-up of the new appointments within the pharma biz, including news from Aduro, Catalent, and Eleven.
ProMetic supplying adsorbent to Chinese biosimilar biz
26-Sep-2011 By Nick Taylor
ProMetic Life Sciences is supplying an affinity adsorbent to a Chinese biopharm for use in scale-up of a biosimilar.
SCM Pharma launches formulation development service
26-Sep-2011 By Alexandria Pesic
UK-based SCM Pharma is to begin offering formulation development services as part of a collaborative deal with the University of Sunderland.
Catalent and Toyobo team up to launch GPEx in Japan
21-Sep-2011 By Natalie Morrison
Catalent has struck up a deal with Toyobo Biologics to launch its cell line engineering technology on the Japanese market.
Pharma discharge checks called for to protect waterways
20-Sep-2011 By Nick Taylor
Researchers have called for closer monitoring of pharma manufacturing discharges after detecting endocrine disruption in fish downstream from a Sanofi plant.
Alkermes moves to Ireland and lands multimillion dollar manufacturing deal
19-Sep-2011 By Gareth Macdonald
Alkermes has celebrated the launch of its new Irish drug delivery and formulation business by winning a new multimillion dollar manufacturing contract with a ‘top 10 pharma.’
GE Healthcare to invest in biomanufacturing tech
19-Sep-2011 By Gareth Macdonald
GE Healthcare will expand its range of biomanufacturing technologies under a new oncology-focused investment project.
ShangPharma eyes discovery biology growth with mAb deal
19-Sep-2011 By Nick Taylor
ShangPharma’s emerging discovery biology services unit has inked another antibody development partnership with a Chinese biopharm.
Biocon building Malaysia plant to serve Pfizer insulin deal
14-Sep-2011 By Nick Taylor
Biocon has begun work on the Malaysian biopharm plant that will serve its deal with Pfizer, and is now providing Lipitor ingredients.
CMC adds capacity at Denmark biologics site
13-Sep-2011
Contract manufacturer CMC Biologics has ramped-up bioreactor capacity to meet demand for biologic drugs for Phase III clinical trials and beyond.
SSB and GE sign patent licensing deal for biomanufacturing techs
13-Sep-2011 By Gareth Macdonald
Sartorius Stedium Biotech (SSB) and GE Healthcare Life Sciences say new cross licensing deal will aid development of their respective biomanufacturing tech offerings.
Cellcura signs HSA-free media deal with IDT for vacc development
07-Sep-2011 By Gareth Macdonald
CellCura has inked an agreement with IDT Biologika for the testing and adaptation of its protein-free (PF) media for the production of cell lines for vaccine manufacturing.
Roche launches biomanufacturing monitoring tech
06-Sep-2011 By Gareth Macdonald
Roche has launched a new analysis platform designed to help bio manufacturers monitor and optimise production operations.
Advantar & DavosPharma ally to broaden service offering
01-Sep-2011 By Nick Taylor
Advantar Labs has allied with DavosPharma to accelerate clients’ development programmes with chemistry and analytical services.
Vaccine cell line demand helps Vivalis cut loss in H1
31-Aug-2011 By Nick Taylor
Vivalis cut its operating loss after demand for its vaccine production cell line drove triple-digit revenue growth.
vivoPharm branch out in US with MPI partnership and new Hershey office
30-Aug-2011 By Natalie Morrison
vivoPharm has extended its oncology offering after striking up an alliance with MPI Research.
Batavia gains bioprocessing assets in Xendo collaboration
29-Aug-2011 By Nick Taylor
Batavia Bioservices has gained access to simulated moving bed (SMB) technology by collaborating with Xendo.
Drug delivery research round up
29-Aug-2011 By Nick Taylor
in-PharmaTechnologist presents a roundup of the latest drug delivery research, including bone marrow targeting nanoparticles and an imaging-treatment combo.
Cyprotex’ H1 income down, but revs soar on US expansion
25-Aug-2011 By Gareth Macdonald
UK preclinical contractor Cyprotex says H1 profits were hit by the loss of it biggest customer, but is upbeat on revenue growth and potential of in vitro toxicity testing business.
Appointments from AAPS, SurModics, Diamedica, and Sirona Biochem – People on the move
25-Aug-2011 By Natalie Morrison
in-PharmaTechnologist presents its latest round-up of the movers and shakers within the pharmaceutical industry, including appointments from AAPS, SurModics, Diamedica, and Sirona Biochem.
New plant moves Irvine into Asia, gives it 2nd media source
25-Aug-2011 By Nick Taylor
Irvine Scientific has begun shipping from the cell culture media plant it built to expand into Asia and give clients the security of a second source.
Unilife creates world's first multi-chamber syringe with in-built safety device
24-Aug-2011 By Natalie Morrison
Unilife has developed the world’s first multi-chamber prefilled syringes that have an in-built safety mechanism.
PBS Biotech buys Integrity to add manufacturing capacity
24-Aug-2011 By Gareth Macdonald
US bioreactor maker PBS Biotech has bought medical device focused CMO Integrity CMI to expand its manufacturing capacity
Takeda gets 24bn yen Govt grant for cell culture vacc plant
23-Aug-2011 By Gareth Macdonald
Japanese drugmaker Takeda has been awarded JPY24bn ($313m) to develop and a cell culture influenza vaccine and establish a commercial-scale production facility.
Strategic deals drive Catalent’s $410m move for Aptuit assets
23-Aug-2011 By Nick Taylor
Catalent is to buy clinical trial supply assets from Aptuit for $410m (€285m) as it adds scale to handle the shift to preferred provider relationships.
Ingredients & formulation research round up
22-Aug-2011 By Nick Taylor
in-PharmaTechnologist presents a roundup of recent ingredient and formulation research, including improved API impurity detection and a simple step to boost stability.
Bioprocessing unit sale could help Repligen, investor says
18-Aug-2011 By Nick Taylor
Repligen should consider selling its bioprocessing unit, which sells materials used in mAb production, to make best use of its assets, a shareholder suggests.
Biosimilar assessment a goal of FDA modernisation plan
18-Aug-2011 By Nick Taylor
The FDA is prioritising development of technologies to compare biosimilars to innovator products in its plan to modernise regulatory science.
Rapid drying tech equivalent to lyophilisation in mAb study
17-Aug-2011 By Nick Taylor
A study shows mAbs processed with fast acting dehydration show equivalent structural changes to freeze dried compounds after a year, EnWave claims.
Encap offers feasibility package for colonic delivery technology
17-Aug-2011 By Natalie Morrison
Encap Drug Delivery now offers a ‘feasibility package’ to assess the potential of its Phoral coating technology as a vehicle for therapy in colonic diseases.
News from CIS, Marken, and MicroConstants – People on the move
16-Aug-2011 By Natalie Morrison
Outsourcing-Pharma brings you the run-down of appointments and changes within the industry, with news from CIS, Marken, and MicroConstants.
News from Creabilis, inVentiv, Omthera and Acura – People on the move
11-Aug-2011 By Natalie Morrison
Outsourcing-Pharma brings you the run-down of appointments and changes within the industry, with news from Creabilis, inVentiv, Omthera and Acura.
apceth gets the go-ahead for somatic cell line production
09-Aug-2011 By Natalie Morrison
Contract manufacturing of somatic cell line therapies is to begin at apceth after the German company received a license.
Outsourcing brings Neovacs to cusp of Ph III partnership
09-Aug-2011 By Nick Taylor
Neovacs is looking to partner for late stage development after using its outsourced model to bring multiple products to Phase II.
Covance establishes more roots in complex contract pharma
04-Aug-2011 By Natalie Morrison
Covance has announced it will collaborate on a genome sequencing project with Broad Institute to create genomic resources for a research model.
Excipient capacity & portfolio expansion in FMC plans
04-Aug-2011 By Nick Taylor
FMC plans to add controlled release technologies and expand excipient production to drive growth at its BioPolymer unit.
News from Quintiles, Novella, Synteract, and PDI – People on the move
04-Aug-2011 By Natalie Morrison
Outsourcing-Pharma brings you the run-down of appointments and changes within the industry.With news from Quintiles, Novella, Synteract, and PDI.
03-Aug-2011 By Gareth Macdonald
Quintiles says the Russian pharmaceutical market is at a tipping point and poised for significant expansion over the next decade.
Engineering can cut protein aggregation during storage
02-Aug-2011 By Nick Taylor
Protein engineering is an untapped method for limiting post-production aggregation that causes immunogenicity, academics say.
Millipore eyes long-term growth beyond Q2 problems
01-Aug-2011 By Nick Taylor
Biosimilars should help Millipore achieve long-term growth but cancellation of an insulin contract and rising raw material costs hit second quarter results.
West adds pricing surcharge to offset rising commodity costs
01-Aug-2011 By Nick Taylor
West has applied a pricing surcharge to offset rising raw material costs that dragged on margins in the second quarter.
Angel calls in local engineering firm to re-commission plant
27-Jul-2011 By Gareth Macdonald
CMO Angel Biotechnologies has called in UK-based engineering group WH Partnership to help re-commissioning its GMP standard biomanufacturing facility in Cramlington near Newcastle-upon-Tyne.
Distribution deals to TAP into SE Asia bioprocessing sector
21-Jul-2011 By Nick Taylor
TAP Biosystems has inked deals with six distributors in South East Asia to extend sales support for its automated bioprocessing systems.
Pall solidifies long-term Engefiltro relationship in take-over
20-Jul-2011 By Natalie Morrison
Filtration, separation and purification technology company Pall is to acquire its long-time Brazilian distribution partner, Engefiltro.
Plant-produced monoclonal antibody enters Phase I
20-Jul-2011 By Nick Taylor
Clinical trials of a monoclonal antibody produced in transgenic tobacco plants, a potentially low-cost, scalable system, have begun in Europe.